Harte Hanks, Inc. (HHS) Fair Value 2026

HHS · Services-Direct Mail Advertising Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.4 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (14/100)

Quick Summary — As of 2026-07-13, Harte Hanks, Inc. (HHS) trades at $2.42, approximately 79% below CirclFi’s Bayesian DCF fair value of $11.67. QOC: 6.4/10. Value Trap Risk: 14/100 (SAFE). 12/13 models active.

Key Facts

Ticker
HHS
Price
$2.42
Quality Score
6.4/10
Value Trap Risk
14/100
Models Active
12/13
Last Updated
Strength: Earnings Power Value suggests +476.6% upside with 71% confidence
Risk: Limited model coverage (12/13) may reduce confidence

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($2.42)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $11.67 +383.4%
Earnings Power Value
High Conviction
 $13.92 +476.6%
CUCE Ensemble
Low Conviction
 $6.93 +186.9%
First Chicago
High Conviction
 $0.69 -71.3%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is Harte Hanks, Inc. (HHS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Harte Hanks, Inc. is potentially undervalued at its current price of $2.42. Based on our 13-model framework, Harte Hanks, Inc.'s intrinsic value is estimated at a composite fair value of $5.34 — representing +121.1% implied upside — with 9 out of 12 active models confirming this thesis. Model dispersion is worth noting: EPV targets $13.92 (+476.6%), versus First Chicago at $0.69 (-71.3%). This +547.9% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, EPV lean bullish — adding weight to the bullish side of the thesis.

What Do the Models Say About HHS?

12 of 13 models are currently active for HHS. Of these, 9 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates HHS's intrinsic value at $11.67, implying +383.4% upside from the current price. See which stocks rank higher →

How Does HHS Rank in Services-Direct Mail Advertising Services?

Among 1 Services-Direct Mail Advertising Services stocks, HHS ranks #1 by Quality of Company score. CirclFi's QOC score of 6.4/10 evaluates 32 fundamental signals. A score of 6.4 indicates above-average quality.

Harte Hanks, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is HHS a Value Trap?

CirclFi's Value Trap algorithm assigns HHS a score of 14/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Harte Hanks, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Harte Hanks, Inc.'s fundamental quality profile registers 6.4/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +547.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HHS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HHS's 12 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Harte Hanks, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Frequently Asked Questions About Harte Hanks, Inc.

What is Harte Hanks, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Harte Hanks, Inc. (HHS) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $11.67. The Quality of Company score is 6.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HHS overvalued or undervalued right now?

At $2.42, 9 of 12 active models suggest HHS may be undervalued, while 3 indicate potential overvaluation. The assessment depends on which methodology best fits Harte Hanks, Inc.'s business model in Services-Direct Mail Advertising Services.

What does a Quality of Company score of 6.4 mean for HHS?

Harte Hanks, Inc.'s QOC of 6.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on HHS?

CirclFi analyzes HHS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is HHS a value trap in 2026?

Harte Hanks, Inc.'s Value Trap score is 14/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on HHS.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access